|
1.
|
K ChanGJ MorrisChemoprevention of breast
cancer for women at high riskSemin
Oncol33642646200610.1053/j.seminoncol.2006.08.01717145342
|
|
2.
|
A JemalA ThomasT MurrayM ThunCancer
statistics, 2002CA Cancer J
Clin522347200210.3322/canjclin.52.1.23
|
|
3.
|
P LazarusA Blevins-PrimeauY ZhengD
SunPotential role of UGT pharmacogenetics in cancer treatment and
prevention: focus on tamoxifenAnn NY Acad
Sci115599111200910.1111/j.1749-6632.2009.04114.x19250197
|
|
4.
|
S GandiniH MerzenichC RobertsonP
BoyleMeta-analysis of studies on breast cancer risk and diet: the
role of fruit and vegetable consumption and the intake of
associated micronutrientsEur J
Cancer36636646200010.1016/S0959-8049(00)00022-8
|
|
5.
|
H AdlercreutzPhyto-oestrogens and
cancerLancet Oncol3364373200210.1016/S1470-2045(02)00777-5
|
|
6.
|
JL LimerV SpeirsPhyto-oestrogens and
breast cancer chemopreventionBreast Cancer
Res6119127200410.1186/bcr78115084232
|
|
7.
|
W CraigHealth-promoting properties of
common herbsAm J Clin Nutr70491499199910479221
|
|
8.
|
JF SavouretM QuesneResveratrol and cancer:
a reviewBiomed
Pharmacother568487200210.1016/S0753-3322(01)00158-512000139
|
|
9.
|
BB AggarwalA BhardwajRS AggarwalNP SeeramS
ShishodiaY TakadaRole of resveratrol in prevention and therapy of
cancer: preclinical and clinical studiesAnticancer
Res2427832840200415517885
|
|
10.
|
YJ CallQY WeiJG FangL YangZL LiuJH WhcheZ
HanThe 3,4-Dihydroxyl groups are important for trans-resveratrol
analogs to exhibit enhanced antioxidant and apoptotic
activitiesAnticancer Res249991002200415161055
|
|
11.
|
SH JeongWS JoSH SongA novel resveratrol
analog, HS-1793, overcomes the resistance conferred by Bcl-2 in
human leukemic U937 cellsBiochem
Pharmacol713371347200910.1016/j.bcp.2009.01.002
|
|
12.
|
SH SongH LeeY JinSyntheses of hydroxy
substituted 2-phenyl-naphthalenes as inhibitors of tyrosinaseBioorg
Med Chem Lett17461464200710.1016/j.bmcl.2006.10.02517064896
|
|
13.
|
SH JeongWS JoSH SongA novel resveratrol
analogue HS-1793 treatment overcomes the resistance conferred by
Bcl-2 and is associated with the formation of mature PML nuclear
bodies in renal clear cell carcinoma Caki-1 cellsInt J
Oncol35135313602009
|
|
14.
|
P DeckerD IsenbergS MullerInhibition of
caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic
cleavage by human PARP autoantibodies and effect on cells
undergoing apoptosisJ Biol
Chem27590439046200010.1074/jbc.275.12.904310722754
|
|
15.
|
JA CallSG EckhardtDR CamidgeTargeted
manipulation of apoptosis in cancer treatmentLancet
Oncol910021011200810.1016/S1470-2045(08)70209-218760670
|
|
16.
|
AK JoeH LiuM SuzuiME VuralD XiaoIB
WeinsteinResveratrol induces growth inhibition, S-phase arrest,
apoptosis, and changes in biomarker expression in several human
cancer cell linesClin Cancer Res88939032002
|
|
17.
|
AW Opipari JrL TanAE BoitanoDR SorensonA
AuroraJR LiuResveratrol-induced autophagocytosis in ovarian cancer
cellsCancer
Res64696703200410.1158/0008-5472.CAN-03-240414744787
|
|
18.
|
J DorrieH GerauerY WachterSJ
ZuninoResveratrol induces extensive apoptosis by depolarizing
mitochondrial membranes and activating caspase-9 in acute
lymphoblastic leukemia cellsCancer Res61473147392001
|
|
19.
|
MV ClementJL HirparaSH ChawdhuryS
PervaizChemo-preventive agent resveratrol, a natural product
derived from grapes, triggers CD95 signaling-dependent apoptosis in
human tumor cellsBlood9299610021998
|
|
20.
|
Y SchneiderF VincentB
DurantonAnti-proliferative effect of resveratrol, a natural
component of grapes and wine, on human colonic cancer cellsCancer
Lett1588591200010.1016/S0304-3835(00)00511-510940513
|
|
21.
|
S BaatoutH DerradjiP JacquetD OomsA
MichauxM MergeayEnhanced radiation-induced apoptosis of cancer cell
lines after treatment with resveratrolInt J Mol
Med13895902200415138632
|
|
22.
|
E Pozo-GuisadoJM MerinoS
Mulero-NavarroResveratrol induced apoptosis in MCF-7 human breast
cancer cells involves caspase independent mechanism with
downregulation of Bcl-2 and NF-κBInt J
Cancer1157484200515688415
|
|
23.
|
SH TsengSM LinJC ChenResveratrol
suppresses the angiogenesis and tumor growth of gliomas in ratsClin
Cancer Res1021902202200410.1158/1078-0432.CCR-03-010515041740
|
|
24.
|
K ViktorssonR LewensohnB
ZhivotovskyApoptotic pathways and therapy resistance in human
malignanciesAdv Cancer
Res94143196200510.1016/S0065-230X(05)94004-916096001
|
|
25.
|
A TaraphdarM RoyR BhattacharyaNatural
products as inducers of apoptosis: Implication for cancer therapy
and preventionCurr Sci80138713962001
|
|
26.
|
RE MewshawRJ Edsall JrC YangER beta
ligands. 3. Exploiting two binding orientations of the
2-phenylnaphthalene scaffold to achieve ER beta selectivityJ Med
Chem4839533979200510.1021/jm058173s15943471
|
|
27.
|
KM DebatinApoptosis pathways in cancer and
cancer therapyCancer Immunol
Immunother53153159200410.1007/s00262-003-0474-814749900
|
|
28.
|
HM KuoHC TsaiYL LinMitochondrial-dependent
caspase activation pathway is involved in baicalein-induced
apoptosis in human hepatoma J5 cellsInt J
Oncol35717724200919724907
|
|
29.
|
WP RoosB KainaDNA damage-induced cell
death by apoptosisTrends Mol
Med12440450200610.1016/j.molmed.2006.07.00716899408
|
|
30.
|
G Van LooX SaelensM Van GurpM MacFarlaneSJ
MartinP Van den AbeeleThe role of mitochondrial factors in
apoptosis: a Russian roulette with more than one bulletCell Death
Differ910311042200212232790
|
|
31.
|
X WangG YangJ ChaiY ShiD XueMechanisms of
AIF-mediated apoptotic DNA degradation in Caenorhabditis
elegansScience29815871592200210.1126/science.107619412446902
|
|
32.
|
N ZamzamiG KroemerThe mitochondrion in
apoptosis: how Pandora’s box opensNat Rev Mol Cell
Biol26771200111413468
|
|
33.
|
SA SusinTwo distinct pathways leading to
nuclear apoptosisJ Exp
Med192571580200010.1084/jem.192.4.57110952727
|
|
34.
|
LY LiX LuoX WangEndonuclease G in an
apoptotic DNase when released from
mitochondriaNature4129599200110.1038/3508362011452314
|
|
35.
|
C CandeI CohenE DaugasApoptosis-inducing
factor (AIF): a novel caspase-independent death effector released
from
mitochondriaBiochimie84215222200210.1016/S0300-9084(02)01374-312022952
|
|
36.
|
JC MartinouS DesagherB AntonssonCytochrome
c release from mitochondria: all or nothingNat Cell
Biol24143200010.1038/3500406910707095
|
|
37.
|
M LiT KondoQL ZhaoApoptosis induced by
cadmium in human lymphoma U937 cells through
Ca2+-calpain and caspase-mitochondria dependent
pathwaysJ Biol
Chem2753970239709200010.1074/jbc.M00736920010970901
|
|
38.
|
GM CohenCaspase: the executioners of
apoptosisBiochem J3261161997
|
|
39.
|
S ShimizuY EguchiW KamiikeH MatsudaY
TsujimotoBcl-2 expression prevents activation of the ICE protease
cascadeOncogene122251225719968649764
|
|
40.
|
RJ YouleA StrasserThe BCL-2 protein
family: opposing activities that mediate cell deathNat Rev Mol Cell
Biol94759200810.1038/nrm230818097445
|
|
41.
|
RT AllenWJ Hunter IIIDK
AgrawalMorphological and biochemical characterization and analysis
of apoptosisJ Pharmacol Toxicol
Meth37215228199710.1016/S1056-8719(97)00033-69279777
|
|
42.
|
TJ PrestonA AbadiL WilsonG
SinghMitochondrial contributions to cancer cell physiology:
potential for drug developmentDrug Deliv
Rev494561200110.1016/S0169-409X(01)00127-211377802
|
|
43.
|
HL XuXF YuAC QuR ZhangXR QuYP ChenXY MaDY
SuiAnti-proliferative effect of Juglone from Juglans mandshurica
Maxim on human leukemia cell HL-60 by inducing apoptosis through
the mitochondria dependent pathwayEur J
Pharmacol6451422201010.1016/j.ejphar.2010.06.07220655907
|
